Intrinsic Value of S&P & Nasdaq Contact Us

Becton, Dickinson and Company BDXA NYSE

NYSE • Healthcare • Medical - Instruments & Supplies • USD

SharesGrow Score
68/100
3/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — BDXA

Becton, Dickinson and Company (BDXA) has a market capitalization of $55.91B and trades at $59.24. The 52-week range is 49.07-64.12.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of 10.1, Earnings Per Share (EPS) of $5.84, annual revenue of $21.84B.

The stock has a beta of 0.00, operates in the Healthcare sector.

Trading Data
Current Price$59.24
52-Week Range49.07-64.12
Volume6.15M
Market Cap$55.91B
Beta (1Y)0.00
Company
IPO Date2017-05-11
ExchangeNYSE
CurrencyUSD
Income (Latest Year)
Revenue$21.84B
Gross Profit$9.92B
EBITDA$4.96B
Operating Income$2.58B
Net Income$1.68B
EPS$5.84
EPS Diluted$5.83
Shares Outstanding$286.61M
Balance Sheet (Latest Year)
Total Assets$55.33B
Current Assets$9.26B
Cash & ST Investments$859M
Total Liabilities$29.94B
Total Debt$19.18B
Net Debt$18.33B
Total Equity$25.39B
Debt / Equity0.76
Valuation Ratios
P/E Ratio10.1
P/S Ratio2.56
P/B Ratio2.2
EV/EBITDA (approx)11.3
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message